Author Question: A client with prostate cancer is being treated with leuprolide (Lupron). The nurse would counsel the ... (Read 69 times)

frankwu · **on:** Jul 23, 2018

A client with prostate cancer is being treated with leuprolide (Lupron). The nurse would counsel the client regarding which side effect?

1. Increased risk of infection
2. Decreased libido and hair loss
3. Nausea with possible vomiting
4. Increased risk of bleeding

Question 2

The major reason pharmacotherapy for male infertility is less successful than pharmacotherapy for female infertility is that:

1. males are typically less compliant in adhering to a medication regimen than are females.
2. endocrine problems affect only about 5 of males.
3. it takes more time to treat male infertility than female infertility.
4. it is more costly to treat male infertility than female infertility.

LVPMS · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 2
Rationale 1: Neutropenia, or an abnormally low neutrophil count, is not an adverse effect.
Rationale 2: Leuprolide (Lupron) is a gonadotropin-releasing hormone agonist that reduces the levels of circulating testosterone. Therefore, it is useful to treat prostatic tumors that respond to testosterone stimulation. The main side effect of leuprolide (Lupron) therapy is drug-induced hypogonadism, resulting in decreased libido.
Rationale 3: Gastrointestinal disturbances are not associated with this drug treatment.
Rationale 4: Disturbances in clotting factors are not an adverse effect.
Global Rationale: Leuprolide (Lupron) is a gonadotropin-releasing hormone agonist that reduces the levels of circulating testosterone. Therefore, it is useful to treat prostatic tumors that respond to testosterone stimulation. The main side effect of leuprolide (Lupron) therapy is drug-induced hypogonadism, resulting in decreased libido.
Neutropenia, GI disturbances, and clotting abnormalities are not expected problems with this drug.

Answer to Question 2

Correct Answer: 2
Rationale 1: This is not the major reason.
Rationale 2: Pharmacotherapy for male infertility is less successful because endocrine problems affect only about 5 of males.
Rationale 3: This is not the major reason.
Rationale 4: This is not the major reason.
Global Rationale: Pharmacotherapy for male infertility is less successful because endocrine problems affect only about 5 of males. The remaining options are not reasons this treatment is less successful.